SMAD9 and neuroblastoma: Similar to the results of SMAD9 expression in NB tumors (Figs. 1D and S2E-S2G), SMAD9 was not an indicator of inferior outcome in nonhigh-risk NB (Fig. S3D) and all NB patients (Fig. S3E).